¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-12
±³À°ÀÏÀÚ : 2020-11-12
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°(½Ç½Ã°£ È­»ó °­ÀÇ)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇѾฮÇÐȸ
´ã´çÀÚ : À庴ȣ 
¿¬¶ôó : 02-326-0370  
À̸ÞÀÏ : head@kosphar.org      
±³À°Á¾·ù : ¾à¸®ÇР     
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 7 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 220,000¿ø      
ºñ°í ÆòÀÇ¿ø, Á¤È¸¿ø: 150,000¿ø ÁØȸ¿ø: 80,000¿ø,ºñȸ¿ø: 220,000¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 12ÀÏ  09:30~09:50 Molecular and Cellular Mechanisms in the Pathogenesis of Chronic Traumatic Encephalopathy (CTE)  ·ùÈÆ(KIST) 
±³À°½Ã°£ 11¿ù 12ÀÏ  09:50~10:10 Lipocalin-2 in the secondary brain injury  ¼®°æÈ£(°æºÏ´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  10:10~10:30 Cerebrovascular recovery after stroke via Plexin-D1 signaling activation  ¿À¿øÁ¾(Çѱ¹³ú¿¬±¸¿ø) 
±³À°½Ã°£ 11¿ù 12ÀÏ  10:30~10:50 Caveolin-1 target microRNA-X attenuates blood-brain injury after cerebral ischemia  ±èÇü¼®(Àü³²´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  09:30~09:50 CTCF-mediated Genomic Effects of BART Region on Epstein-Barr virus 3D Chromatin Structure  °­È¿Á¤(°æºÏ´ë ¾à´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  09:50~10:10 Application of nanobiotechnology for diagnosis and prevention against spillover viral infections Disease X  ¼Û´ë¼·(°í·Á´ë ¾à´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  10:10~10:30 Identification of Antiviral Drug Candidates against SARS-CoV-2 FDA-Approved Drugs  ±è½ÂÅÃ(Çѱ¹ ÆĽºÅ𸣿¬±¸¼Ò) 
±³À°½Ã°£ 11¿ù 12ÀÏ  10:30~10:50 Development of Antiviral Agents: Influenza, Zika and Coronavirus  ±èÁ¤±â(°í·Á´ë ¾à´ë) 
Åä·Ð 11¿ù 12ÀÏ  10:50~11:10 ÁúÀÇ ¹× ÀÀ´ä  () 
È޽Ġ11¿ù 12ÀÏ  11:10~11:30 Coffee Break  () 
±³À°½Ã°£ 11¿ù 12ÀÏ  11:30~12:20 Smart Mouse Model for Precision Medicine  ¼ºÁ¦°æ(¼­¿ï´ë) 
½Ä»ç 11¿ù 12ÀÏ  12:20~13:20 Á߽Ġ () 
±âŸ 11¿ù 12ÀÏ  13:20~14:20 Æ÷½ºÅÍ ¼¼¼Ç  () 
±³À°½Ã°£ 11¿ù 12ÀÏ  14:20~14:40 Molecular deconvolution identifies &quotmesenchymal-ness  Á¤ÀçÈ£(¿¬¼¼´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  14:40~15:00 Immunotherapy for complicated pregnancy associated and cellular immune abnormality  À̼º±â(°Ç¾ç´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  15:00~15:20 Leukocyte Specific Protein (LSP)-1 Regulation of Lymphocyte Functions  ±è¿Ï¿í(°¡Å縯´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  15:20~15:40 Translational approaches discovery to clinical proof of concept  ÀÓµ¿¼®(°¡Å縯´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  14:20~14:40 Data Driven Drug Discovery Research Platform at Korea Chemical Bank  À̼±°æ(È­Çבּ¸¿ø) 
±³À°½Ã°£ 11¿ù 12ÀÏ  14:40~15:00 Induced Pluripotent Stem Cell in Disease Modelling and Drug Screening Platform  ÀÌÀçö(¼º±Õ°ü´ë ¾à´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  15:00~15:20 Silicon neural probe for modulation and measurement of neural activities in vivo and in vitro  Á¶ÀÏÁÖ(KIST) 
±³À°½Ã°£ 11¿ù 12ÀÏ  15:20~15:40 Long-term 3D culture of primary hepatocyte in nanofibrous membrane  °ûÁ¾¿µ(¾ÆÁÖ´ë ÀÇ´ë) 
Åä·Ð 11¿ù 12ÀÏ  15:40~17:00 ÁúÀÇ ¹× ÀÀ´ä  () 
±âŸ 11¿ù 12ÀÏ  16:00~16:30 ½Ã»ó½Ä - Æóȸ½Ä  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ÀÇ·á À±¸®ÀÇ ÀÌÇØ : 2020-11-12
´ÙÀ½±Û ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ÃæºÏÁöȸ ¿¬¼ö°­Á : 2020-11-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
572 °æ±â ´ëÇÑôÃß¿Ü°úÇÐȸ °æÀÎÁöȸ 2018³â Ãß°èÇмú´ëȸ : 2018-09-08 0 805 2018-08-29
571 ´ë±¸ ´ëÇѺñ´¢±â°úÇÐȸ ¼Ò¾Æºñ´¢ : 2018-09-07 0 998 2018-08-29
570 °­¿ø °­¸ª¾Æ»êº´¿ø 2018³â ´ëÇÑÀӻ󵶼ºÇÐȸ Çмú´ëȸ : 2018-09-07 0 847 2018-08-29
569 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ Pediatric CRRT 2018 : 2018-09-07 0 990 2018-08-29
568 ´ëÀü °Ç¾ç´ëÇб³ Á¦92Â÷ ´ëÇѽŰæ¿Ü°úÇÐȸ ´ëÀüÃæûÁöȸ Çмú Áý´ãȸ : 2018-09-07 0 1,191 2018-08-29
567 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-06 0 701 2018-08-29
566 ´ë±¸ µ¿»êº´¿ø ´ëÇÑ¿µ»óÀÇÇÐȸ ´ë±¸°æºÏÁöȸ 9¿ù Áý´ãȸ : 2018-09-06 0 1,018 2018-08-29
565 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ôÃߺ´¿ø 9¿ù ¿ù·ÊÁý´ãȸ : 2018-09-06 0 2,683 2018-08-29
564 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¾È°úÇб³½Ç Áý´ãȸ : 2018-09-06 0 874 2018-08-29
563 °æ±â ¾ÆÁÖ´ëÇк´¿ø ºñ´¢ÀÇÇаú Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-06 1 771 2018-08-29
562 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2018³â ´ëÇѼöÇ÷ÇÐȸ ÇмúÁý´ãȸ : 2018-09-06 0 704 2018-08-29
561 ÀÎõ °¡ÃµÀÇ´ë±æº´¿ø °íÀ§Çè »ê¸ð½Å»ý¾Æ ÅëÇÕÄ¡·á¼¾ÅÍ ¿ªÇÒ ¹× ¿î¿µ¹æÇâ : 2018-09-06 [2] 0 1,324 2018-08-29
560 ¼­¿ï °í´ë¾È¾Ïº´¿ø ¼Ò¾Æû¼Ò³â°ú ¿ù·Ê Áý´ãȸ : 2018-09-05 0 836 2018-08-29
559 °æ±â ´ëÇÑÀÓ»ó°Ë»çÁ¤µµ°ü¸®ÇÐȸ 2018³âµµ Ãß°èÇмú´ëȸ : 2018-09-05 0 1,303 2018-08-29
558 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦ 3Â÷ °³¿øÀǸ¦ À§ÇÑ ´ëÇѺÎÁ¤¸ÆÇÐȸ ¿¬¼ö±³À° : 2018-09-04 0 1,146 2018-08-29
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷